Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00248872 · ClinicalTrials.gov registry record · NA

A Randomized Trial of Changing Medication Adherence In Hypertensive African-American Patients

A NA study of Hypertension, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
278
Enrollment target
1
Study location

NCT00248872 is a NA study of Hypertension that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 278 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00248872, a NA study of Hypertension, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
278 participants
Enrollment target
1
Study location

Study Summary

The long-term objective is to determine whether better adherence to prescribed medications can be achieved through positive affect induction and self-affirmation leading to reduction in hypertension-related outcomes such as end-stage renal disease, stroke, and cardiovascular mortality among African American patients with poorly controlled hypertension.

Conditions Studied

Interventions

  • BEHAVIORAL Intervention Group

Study Locations (1)

New York

  • The New York Presbyterian Hospital-Weill Medical Center - New York

Trial Details

FieldValue
Enrollment Target 278 participants
Start Date 2004-10
Est. Completion 2008-07
Phase NA

What the Registry Record Tells You About NCT00248872

The ClinicalTrials.gov registry entry for NCT00248872 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 278 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (92% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Intervention Group is the first listed.

NCT00248872 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00248872 about?

NCT00248872 is a clinical study titled "A Randomized Trial of Changing Medication Adherence In Hypertensive African-American Patients". The long-term objective is to determine whether better adherence to prescribed medications can be achieved through positive affect induction and self-affirmation leading to reduction in hypertension-related outcomes such as end-stage renal disease, stroke, and cardiovascular mortality among African ...

What is the current status of trial NCT00248872?

This trial is currently completed. It is a NA study. The enrollment target is 278 participants. The study started on 2004-10. Estimated completion is 2008-07.

What conditions does trial NCT00248872 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT00248872?

The interventions under investigation include: Intervention Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT00248872?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00248872 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.